Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

115.71
Delayed Data
As of 4:14pm ET
 -1.22 / -1.04%
Today’s Change
94.42
Today|||52-Week Range
127.64
-0.03%
Year-to-Date

Today’s Trading

Previous close116.93
Today’s open116.50
Day’s range113.63 - 116.69
Volume5,685,232
Average volume (3 months)3,762,654
Market cap$91.3B
Dividend yield--
Data as of 4:14pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+22.68%
Earnings growth (next 5 years)+20.02%
Revenue growth (last year)+22.70%
P/E ratio43.5
Price/Sales8.51
Price/Book13.80

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.08+0.15%
LLYEli Lilly and Co-0.82-1.05%
AZNAstraZeneca+0.05+0.15%
ABBVAbbVie-0.14-0.21%
Data as of 4:02pm ET, 05/22/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$1.78
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts